Viacyte Pioneers Stem Cell Cure for Diabetes
seen from Malaysia

seen from Malaysia
seen from China

seen from United Kingdom

seen from United States

seen from United States

seen from United Kingdom

seen from United States
seen from Azerbaijan

seen from Saudi Arabia
seen from Guam
seen from United States
seen from Saudi Arabia
seen from United States
seen from China

seen from United States

seen from United States
seen from Saudi Arabia

seen from Singapore
seen from United Kingdom
Viacyte Pioneers Stem Cell Cure for Diabetes
Can VC-01, Viacyte's Stem Cell Device, Treat Diabetes Type 1?
KZSU Interviewed Dr. Paul Laikind. Viacyte’s CEO:
Viacyte developed VC-01 after more than 15 years of research on using stem cell technology to treat Diabetes Type 1. VC-01 is now in clinical trials in the US and Canada to test if it's stem cell therapy can help treat Diabetes Type 1. In his interview with KZSU, Dr. Laikind discussed how VC-01 works, how this technology has cured diabetes in the animal model, how VC-01 might help treat patients with Type 1 Diabetes and how to find out about the clinical trials of VC-01. Dr. Laikind described how Viacyte started and became the leader in the field of stem cell technology for treating Diabetes; Viactye holds over 100 patents in this research, with over 150 patents pending as of March, 2014. Dr. Laikind also discussed how JDRF and the California Institute for Regenerative Medicine (CIRM) have helped fund some of the work that went into making VC-01 successful so far. This interview was broadcast on KZSU on December 9, 2015 and is available from this link.
Diabetes Stem Cell Milestone: ViaCyte Transplants 1st Patient
Diabetes Stem Cell Milestone: ViaCyte Transplants 1st Patient
Chalk up another exciting development for the stem cell and regenerative medicine field in 2014. It’s been a huge year.
For the first time ever, an ES cell-based device has been transplanted into a Diabetic patient.
ViaCyte working together with Dr. Robert Henry at UCSD did the pioneering transplant, the first in a series as part of an FDA-approved clinical trial being conducted as UCSD Health…
View On WordPress